Published December 2018
| Version v1
Journal article
Translational molecular imaging in exocrine pancreatic cancer
Creators
- 1. Oxford University, CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, Oxford (United Kingdom)
- 2. Istituto Oncologico Veneto I.R.C.C.S., Padova (Italy)
- 3. Vrije Universiteit Brussel, Brussels (Belgium)
- 4. Universitaetsspital Basel, Department of Radiology, Basel (Switzerland)
- 5. Universita' degli Studi di Napoli ''Federico II'', Naples (Italy)
- 6. CRCINA, INSERM, CNRS, Universite d'Angers, Universite de Nantes, Nantes (France)
- 7. Erasmus MC, Department of Radiology and Nuclear Medicine, Rotterdam (Netherlands)
- 8. Leiden University Medical Center, Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden (Netherlands)
Description
Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-018-4146-5Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 45
- Journal Issue
- 13
- Journal Page Range
- p. 2442-2455
- ISSN
- 1619-7070
- CODEN
- EJNMA6
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 50004179
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANTIBODIES; ANTIGENS; BLOOD SERUM; CARCINOMAS; CATHEPSINS; CHEMOTHERAPY; COMBINED THERAPY; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; FLUORINE 18; FLUORODEOXYGLUCOSE; NUCLEOTIDES; PANCREAS; PEPTIDES; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SIDE EFFECTS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; THYMIDINE; TRANSFERRIN; UPTAKE
- Descriptors DEC
- ANTIMETABOLITES; AZINES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BIOLOGICAL MATERIALS; BLOOD; BLOOD PLASMA; BODY; BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; ENDOCRINE GLANDS; ENZYMES; FLUORINE ISOTOPES; GLANDS; GLOBULINS; GLOBULINS-BETA; HETEROCYCLIC COMPOUNDS; HOURS LIVING RADIOISOTOPES; HYDROLASES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MEDICINE; METALLOPROTEINS; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; NUCLEOSIDES; NUCLEOTIDES; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PEPTIDE HYDROLASES; PROTEINS; PYRIMIDINES; RADIOACTIVE MATERIALS; RADIOISOTOPES; RIBOSIDES; SH-PROTEINASES; THERAPY; TOMOGRAPHY